Concepedia

Amy R. Dunn

AR

Statistics

Publications

16

Citations

836

H-Index

14

Active since

2008

Affiliations

Emory University(Current)

Jackson Laboratory

University of Toronto

Columbia University Irving Medical Center

National Institute of Neurological Disorders and Stroke

Amy R. Dunn is an author at Emory University specializing in neuroscience, life sciences, and molecular neuroscience.

ORCID

Publications per year

2008–2024

16

Publications

16

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo

Kelly M. Lohr, Alison I. Bernstein, Kristen A. Stout et al. · Proceedings of the National Academy of Sciences · 2014 · 239 citations · Full text

, , +17

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Amy R. Dunn, Kristen A. Stout, Minagi Ozawa et al. · Proceedings of the National Academy of Sciences · 2017 · 153 citations · Full text

, , +17

Increased Vesicular Monoamine Transporter 2 (VMAT2;<i>Slc18a2</i>) Protects against Methamphetamine Toxicity

Kelly M. Lohr, Kristen A. Stout, Amy R. Dunn et al. · ACS Chemical Neuroscience · 2015 · 70 citations

, , +17

Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals

Kelly M. Lohr, Merry Chen, Carlie Hoffman et al. · Toxicological Sciences · 2016 · 53 citations · Full text

, , +17

Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo

Laura M. Vecchio, Patricia Sullivan, Amy R. Dunn et al. · Journal of Neurochemistry · 2021 · 51 citations · Full text

, , +17

1–5 of 16